Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Jan;48(1):323-5.
doi: 10.1128/AAC.48.1.323-325.2004.

In vitro activities of tigecycline against erythromycin-resistant Streptococcus pyogenes and Streptococcus agalactiae: mechanisms of macrolide and tetracycline resistance

C Betriu  1 , E Culebras, I Rodríguez-Avial, M Gómez, B A Sánchez, J J Picazo
Affiliations

In vitro activities of tigecycline against erythromycin-resistant Streptococcus pyogenes and Streptococcus agalactiae: mechanisms of macrolide and tetracycline resistance

C Betriu et al. Antimicrob Agents Chemother. 2004 Jan.

Abstract

The activity of tigecycline was tested against erythromycin-resistant streptococci (107 Streptococcus pyogenes and 98 Streptococcus agalactiae strains). The presence of erythromycin and tetracycline resistance genes was determined by PCR. Among S. pyogenes strains the most prevalent gene was mef(A) (91.6%). The erm(B) gene was the most prevalent (65.3%) among S. agalactiae strains. Tigecycline proved to be very active against all the isolates tested (MIC at which 90% of the isolates tested were inhibited, 0.06 micro g/ml), including those resistant to tetracycline.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Betriu, C., M. C. Casado, M. Gómez, A. Sánchez, M. L. Palau, and J. J. Picazo. 1999. Incidence of erythromycin resistance in Streptococcus pyogenes: a 10-year study. Diagn. Microbiol. Infect. Dis. 33:255-260. - PubMed
    1. Betriu, C., E. Culebras, M. Gómez, I. Rodríguez-Avial, B. A. Sánchez, M. C. Ágreda, and J. J. Picazo. 2003. Erythromycin and clindamycin resistance and telithromycin susceptibility in Streptococcus agalactiae. Antimicrob. Agents Chemother. 47:1112-1114. - PMC - PubMed
    1. Betriu, C., E. Culebras, M. Redondo, I. Rodríguez-Avial, M. Gómez, A. Boloix, and J. J. Picazo. 2002. Prevalence of macrolide and tetracycline resistance mechanisms in Streptococcus pyogenes isolates and in vitro susceptibility to telithromycin. J. Antimicrob. Chemother. 50:436-438. - PubMed
    1. Betriu, C., I. Rodríguez-Avial, B. A. Sánchez, M. Gómez, J. Álvarez, J. J. Picazo, and Spanish Group of Tigecycline. 2002. In vitro activities of tigecycline (GAR-936) against recently isolated clinical bacteria in Spain. Antimicrob. Agents Chemother. 46:892-895. - PMC - PubMed
    1. Cornaglia, G., M. Ligozzi, A. Mazzariol, L. Masala, G. Lo Cascio, G. Orefici, R. Fontana, et al. 1998. Resistance of Streptococcus pyogenes to erythromycin and related antibiotics in Italy. Clin. Infect. Dis. 27(Suppl. 1):S87-S92. - PubMed

Publication types

MeSH terms